Randomized Controlled Crossover Trial of a New Oscillatory Device as Add-On Therapy for COPD

References

• Global initiative for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Pocket guide to COPD diagnosis, management, and prevention. A guide for health care professionals. Journal (serial on the Internet). 2010 Date: Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Pocket_2010Mar31.pdf. (Accessed July 31, 2011).
   Google Scholar
• Niewoehner DE. Clinical practice. Outpatient management of severe COPD. N Engl J Med 2010 Apr 15; 362(15):1407–1416.
   PubMed Web of Science ®Google Scholar
• Casaburi R, ZuWallack R. Pulmonary rehabilitation for management of chronic obstructive pulmonary disease. N Engl J Med 2009 Mar 26; 360(13):1329–1335.
   PubMed Web of Science ®Google Scholar
• Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006(4):CD003793.
   PubMed Web of Science ®Google Scholar
• Edo H, Kimura H, Niijima M, Sakabe H, Shibuya M, Kanamaru A, Homma I, Kuriyama T. Effects of chest wall vibration on breathlessness during hypercapnic ventilatory response. J Appl Physiol 1998 May; 84(5):1487–1491.
   PubMed Web of Science ®Google Scholar
• Hardinge FM, Davies RJ, Stradling JR. Effects of short term high frequency negative pressure ventilation on gas exchange using the Hayek oscillator in normal subjects. Thorax 1995 Jan; 50(1):44–49.
   PubMed Web of Science ®Google Scholar
• Spitzer SA, Fink G, Mittelman M. External high-frequency ventilation in severe chronic obstructive pulmonary disease. Chest 1993 Dec; 104(6):1698–1701.
   PubMed Web of Science ®Google Scholar
• Sibuya M, Yamada M, Kanamaru A, Tanaka K, Suzuki H, Noguchi E, Altose MD, Homma I. Effect of chest wall vibration on dyspnea in patients with chronic respiratory disease. Am J Respir Crit Care Med 1994 May; 149(5):1235–1240.
   PubMed Web of Science ®Google Scholar
• Mason TJ. Therapeutic ultrasound an overview. Ultrason Sonochem 2011 Jul; 18(4):847–852.
   PubMed Web of Science ®Google Scholar
• ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002 Jul 1; 166(1):111–117.
   PubMed Web of Science ®Google Scholar
• Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993 Mar; 16:5–40.
   PubMedGoogle Scholar
• Schunemann HJ, Guyatt GH, Stahl E, Stubbing D, Mador J, McKim D, Austin P, Goldstein R. Validation of a new version of the chronic respiratory questionnaire (CRQ): the self-administred standardized CRQ. Eur Respir J 2002; 20:156S.
   Google Scholar
• Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol 1994 Jan; 47(1):81–87.
   PubMed Web of Science ®Google Scholar
• Redelmeier DA, Guyatt GH, Goldstein RS. Assessing the minimal important difference in symptoms: a comparison of two techniques. J Clin Epidemiol 1996 Nov; 49(11):1215–1219.
   PubMed Web of Science ®Google Scholar
• Holland AE, Hill CJ, Rasekaba T, Lee A, Naughton MT, McDonald CF. Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2010 Feb; 91(2):221–225.
   PubMed Web of Science ®Google Scholar
• Puhan MA, Mador MJ, Held U, Goldstein R, Guyatt GH, Schunemann HJ. Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J 2008 Sep; 32(3): 637–643.
   PubMed Web of Science ®Google Scholar
• Koehne-Voss S, Schmidli H, Smith DM, Pigeot I. The impact of period effects on dose level contrasts in alternating cross-over designs for first-time-in-human studies. Pharm Stat 2011 Jan; 10(1):45–49.
   PubMed Web of Science ®Google Scholar
• Heller SR, Amiel SA, Mansell P. Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group. Diabetes Care 1999 Oct; 22(10):1607–1611.
   PubMed Web of Science ®Google Scholar
• Johnson KE, Sanders JJ, Gellin RG, Palesch YY. The effectiveness of a magnetized water oral irrigator (Hydro Floss) on plaque, calculus and gingival health. J Clin Periodontol 1998 Apr; 25(4):316–321.
   PubMed Web of Science ®Google Scholar
• Van Gestel AJ, Kohler M, Steier J, Teschler S, Russi EW, Teschler H. Cardiac autonomic dysfunction and health-related quality of life in patients with chronic obstructive pulmonary disease. Respirology 2011 Aug;16(6):939–946.
   PubMed Web of Science ®Google Scholar
• Petros AJ, Fernando SS, Shenoy VS, al-Saady NM. The Hayek oscillator. Nomograms for tidal volume and minute ventilation using external high frequency oscillation. Anaesthesia 1995 Jul; 50(7):601–606.
   PubMed Web of Science ®Google Scholar
• Kempainen RR, Williams CB, Hazelwood A, Rubin BK, Milla CE. Comparison of high-frequency chest wall oscillation with differing waveforms for airway clearance in cystic fibrosis. Chest 2007 Oct; 132(4):1227–1232.
   PubMed Web of Science ®Google Scholar
• Konstan MW, Stern RC, Doershuk CF. Efficacy of the Flutter device for airway mucus clearance in patients with cystic fibrosis. J Pediatr 1994 May; 124(5 Pt 1):689–693.
   PubMed Web of Science ®Google Scholar
• Marks JH, Hare KL, Saunders RA, Homnick DN. Pulmonary function and sputum production in patients with cystic fibrosis: a pilot study comparing the PercussiveTech HF device and standard chest physiotherapy. Chest 2004 Apr; 125(4):1507–1511.
   PubMed Web of Science ®Google Scholar
• Myers TR. Positive expiratory pressure and oscillatory positive expiratory pressure therapies. Respir Care 2007 Oct; 52(10):1308–1326; discussion 27.
   PubMed Web of Science ®Google Scholar
• Alves LA, Pitta F, Brunetto AF. Performance analysis of the Flutter VRP1 under different flows and angles. Respir Care 2008 Mar; 53(3):316–323.
   PubMed Web of Science ®Google Scholar
• Cantin AM, Bacon M, Berthiaume Y. Mechanical airway clearance using the frequencer electro-acoustical transducer in cystic fibrosis. Clin Invest Med 2006 Jun; 29(3):159–165.
   PubMed Web of Science ®Google Scholar
• Marks JH, Homnick DN, Hare KL, Cucos D. The Percussivetech HF compared to the Flutter device in cystic fibrosis patients: a six month pilot study. Journal (serial on the Internet). 1999 Date: Available from: http://www.vortran.com/images/stories/printables/P-NEB-User-Guide.pdf (Accessed July 31, 2011).
   Google Scholar
• Volsko TA, DiFiore J, Chatburn RL. Performance comparison of two oscillating positive expiratory pressure devices: Acapella versus Flutter. Respir Care 2003 Feb; 48(2):124–130.
   PubMedGoogle Scholar
• Homma I, Obata T, Sibuya M, Uchida M. Gate mechanism in breathlessness caused by chest wall vibration in humans. J Appl Physiol 1984 Jan; 56(1):8–11.
   PubMed Web of Science ®Google Scholar
• Shen X, Wu MF, Tepper RS, Gunst SJ. Mechanisms for the mechanical response of airway smooth muscle to length oscillation. J Appl Physiol 1997 Sep; 83(3):731–738.
   PubMed Web of Science ®Google Scholar
• Plowman L, Edwards PH, Lauff DC, Berthon-Jones M, Sullivan CE. Tracheal smooth muscle responses to upper airway pressure in conscious dogs. J Appl Physiol 1990 Apr; 68(4):1555–1561.
   PubMed Web of Science ®Google Scholar
• Fagevik Olsen M, Westerdahl E. Positive expiratory pressure in patients with chronic obstructive pulmonary disease—a systematic review. Respiration 2009; 77(1):110–118.
   PubMed Web of Science ®Google Scholar
• Holanda MA, Fortaleza SC, Alves-de-Almeida M, Winkeler GF, Reis RC, Felix JH, Lima JW, Pereira ED. Continuous positive airway pressure effects on regional lung aeration in patients with COPD: a high-resolution CT scan study. Chest 2010 Aug; 138(2):305–314.
   PubMed Web of Science ®Google Scholar